Skip to content

Bausch + Lomb Seeks $840 Million in U.S. IPO of Contact-Lens Maker

Bloomberg staffer Sara Marley puts in her contact lens at he
Photographer: Suzanne Plunkett/Bloomberg

Bausch + Lomb Corp., the contact lens maker, has filed to raise as much as $840 million in an initial public offering, a long-awaited deal that may show green shoots in U.S. capital markets. 

The company being spun out of Bausch Health Cos. plans to sell 35 million shares for $21 to $24 apiece, according to a filing Thursday with the U.S. Securities and Exchange Commission. All of the proceeds from the IPO will go to Bausch Health as the selling shareholder, the filing shows.